Proven Industry Leadership
Jamie Platt PhD, MB (ASCP)
CEO & Founder
Jamie Platt has more than 15 Years of Leadership in Next Generation Sequencing and Clinical Diagnostics. She has propelled and directed a global $4.7B Fortune 500 diagnostics provider into the emerging genomics market through adoption of NGS technology; Spearheaded the development & validation of the first NGS-based HIV test for a large commercial reference lab (secured NYS approval) and increased revenue by $1M within 6 months of launch. Jamie has a strong track record of building NGS-based Genomics programs with FDA-aligned, design control development QMS and ISO 15189 readiness for growth from clinical into Pharma services markets.
-
Assay Development and Validation
-
Commercialization
-
High-Complexity Molecular Testing
-
Emerging Technology Market Assessment
-
Implementation of New Technologies in Clinical Diagnostics
-
Clinical Trials for Pharma and Device Manufacturers
-
Genomics program development and pipeline strategies
-
Strategic development and M & A’s
Selected Peer Reviewed Publications
-
CLSI.Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine; Approved Guideline – Second Edition.CLSI document MM09-A2. Wayne, PA. Clinical and Laboratory Standards Institute; 2014.
-
Development and Validation of a Next-Generation Sequencing Assay for and Variants for the Clinical Laboratory. 2015. PLoS ONE 10(8): e0136419. doi:10.1371/journal.pone.0136419
-
A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients. 2012. PLoS ONE 7(9): e46334. doi:10.1371/journal.pone.0046334
Network of Industry Professionals
Bridgenomics has access to over 2,500+ professional network of KOLs, leaders, development scientists, end users, and investors. Including:
-
High-complexity CLIA Lab Directors (ABMGG, HCLD(ABB), ABMM, ABMLI)
-
Medical Directors with NGS experience
-
Quality Specialists and Regulatory Experts (ASQ CQPA and others)
-
Licensed, NGS-experienced Medical Technologists, including California (CGMBS)
-
Field Application Specialists and Molecular Assay Development Scientists (including PhDs)
-
Experienced Bioinformaticians, Linux gurus, and IT Security Experts
-
Six Sigma Black Belts and Lean for Six Sigma and Design for Six Sigma experts
-
Medical writers and marketing experts